Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Director Shareholding - AMENDMENT

20 Jul 2016 16:59

RNS Number : 7875E
First Derivatives PLC
20 July 2016
Β 

20 July 2016

Β 

Amendment of RNS 6526E published at 17:03 on 19 July 2016 - The only amendment made to the below announcement is to change the date of admission of the new Ordinary Shares to trading on AIM and ESM from 22 July 2016 to 25 July 2016

Β 

First Derivatives plc

("FD" or the "Company")

Β 

Director dealing and issue of equity

Β 

Β 

FD (AIM: FDP.L, ESM: FDP.I) announces that on 18 July 2016 certain employees and a Director exercised options over a total of 217,000 ordinary shares of 0.5p each in the Company ("Ordinary Shares"). Of this total exercise, Graham Ferguson, Chief Financial Officer, exercised 150,000 share options and on the same day sold 170,000 Ordinary Shares at a price of 1,725p per share. On 19 July Mr Ferguson sold a further 30,000 Ordinary Shares at a price of 1,725p. Following these transactions Mr Ferguson holds a total of 122,647 Ordinary Shares representing 0.5% of the total issued share capital of the Company.

Β 

Furthermore, on 19 July 2016 Mr Ferguson was awarded 200,000 share options over Ordinary Shares. These options have an exercise price of 1,717p per share and will vest on the third anniversary of the date of the award, subject to meeting demanding performance criteria related to the achievement of total shareholder returns during this period. Following this award, Mr Ferguson holds share options over a total of 200,000 Ordinary Shares.

Β 

As a result of the above exercise of options, application has been made for 217,000 new Ordinary Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 25 July 2016. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares. Following this allotment, the total issued share capital of the Company will increase to 24,531,639 Ordinary Shares.

Β 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Β 

Β 

Investec Bank plc (Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

Β 

Β 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

Β 

Β 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

Β 

+44 (0)20 7933 8780

Β 

Β 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,600 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

Β 

For further information, please visit www.firstderivatives.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHRMMATMBATBLF
Date   Source Headline
30th Sep 20191:20 pmRNSTotal Voting Rights
9th Sep 20197:00 amRNSEuronext Growth Dublin Notice
3rd Sep 20194:09 pmRNSIssue of Equity
2nd Sep 20194:35 pmRNSHolding(s) in Company
1st Aug 20198:01 amRNSTotal Voting Rights
1st Aug 20197:00 amRNSEuronext Growth Dublin Notice
31st Jul 20197:38 amRNSHolding(s) in Company
29th Jul 20197:00 amRNSStatement regarding Brian Conlon
26th Jul 20193:24 pmRNSIssue of Equity
19th Jul 201912:00 pmRNSHolding(s) in Company
9th Jul 20198:03 amRNSAdmission of Shares
9th Jul 20197:00 amRNSEuronext Growth Dublin Notice
8th Jul 20194:31 pmRNSHolding(s) in Company
5th Jul 20195:31 pmRNSHolding(s) in Company
3rd Jul 20197:00 amRNSIssue of Equity
2nd Jul 20195:42 pmRNSProposed Secondary Placing
28th Jun 20191:10 pmRNSHolding(s) in Company
27th Jun 20193:48 pmRNSAGM Statement
18th Jun 20197:00 amRNSAcquisition of minority interest in Kx Systems
4th Jun 20194:11 pmRNSNotice of AGM
31st May 20193:35 pmRNSTotal Voting Rights
31st May 20197:00 amRNSEuronext Growth Dublin Notice
24th May 20196:19 pmRNSIssue of Equity
21st May 20197:00 amRNSFull year results for the year ended 28 Feb 2019
17th May 20197:00 amRNSStatement regarding Brian Conlon
18th Apr 20197:00 amRNSTrading Statement and Notice of Results
29th Mar 20192:29 pmRNSTotal Voting Rights
20th Mar 20197:00 amRNSEuronext Growth Dublin Notice
13th Mar 20194:52 pmRNSIssue of Equity
12th Feb 20194:05 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSCapital Markets Day
6th Feb 20197:00 amRNSExtended Bank Facilities on Improved Terms
31st Jan 201911:00 amRNSTotal Voting Rights
9th Jan 20197:00 amRNSNotice of Capital Markets Day
21st Dec 20185:07 pmRNSIssue of Equity
6th Nov 20187:00 amRNSInterim Results
17th Oct 20187:00 amRNSOEM agreement with BISTel
11th Oct 20187:00 amRNSNotice of Results
28th Sep 20183:31 pmRNSTotal Voting Rights
7th Sep 20188:00 amRNSEnterprise Securities Market Notice
31st Aug 20183:26 pmRNSIssue of Equity
31st Aug 20189:03 amRNSTotal Voting Rights
10th Aug 20187:00 amRNSEnterprise Securities Market Notice
3rd Aug 20184:14 pmRNSIssue of Equity
31st Jul 201811:07 amRNSTotal Voting Rights
31st Jul 201811:02 amRNSTotal Voting Rights
16th Jul 20187:00 amRNSEuropean Energy Market Contract Win
12th Jul 20187:00 amRNSEnterprise Securities Market Notice
9th Jul 20185:50 pmRNSHolding(s) in Company
6th Jul 20185:03 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.